Atlanta, GA – Today, Senior Pastor of Ebenezer Baptist Church and Democratic nominee for U.S. Senate Reverend Raphael Warnock issued the following statement on Senator Kelly Loeffler’s failed attempt to cover up her health care record:
“Instead of finally getting serious about this issue, Kelly Loeffler is trying to cover up her record of opposing health care – even in the middle of the pandemic. She hasn’t outlined a single policy that will make sure insurance companies cannot discriminate against people if they have asthma, diabetes, heart disease or another condition and is even working to help those companies expand junk insurance plans that can deny coverage to people with a pre-existing condition. I’m in this race to fight for quality health care people can afford, and Georgia voters will not be fooled by this distraction that is just another example of Senator Loeffler looking out for herself.”
Here’s what you need to know about Loeffler’s sham plan:
- Loeffler’s proposal would codify into law the junk insurance plans pushed by the Trump Administration, which are not required to cover pre-existing conditions, can impose coverage limits, and allow insurers to keep massive amounts of their profits instead of investing in patients’ health care.
- Loeffler’s proposal encourages states to follow Georgia’s new waiver eliminating use of healthcare.gov to help Georgian’s enroll in health insurance. Brookings predicts could result in 100,000 fewer Georgians getting insurance.
Loeffler has backed efforts to repeal the Affordable Care Act, saying she is “100% supportive” of President Trump’s agenda, which includes a lawsuit to invalidate the Affordable Care Act, including protections for 1.8 million Georgians living with pre-existing conditions. In October, she cast a vote in support of that lawsuit.
In the Senate, Reverend Warnock would fight to protect, improve and build in the Affordable Care Act; encourage Medicaid expansion in Georgia and support rural and urban hospitals; and support legislation to lower the costs of prescription drugs, including legislation to authorize the federal government to negotiate with drug companies to bring down prices.
Title and affiliation are provided for identification purposes only.